CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
research
MicroRNA expression profiles in pediatric dysembryoplastic neuroepithelial tumors.
Authors
A Ranger
A Spalice
+35 more
A Tessitore
B Zhang
C Wang
DK Birks
DN Louis
E Ferretti
E. Kanavakis
F Chassoux
F Ozlen
F Wang
G Cui
G Della Vittoria Scarpati
G. I. Lambrou
I Qaddoumi
J Cai
J Qiao
K Yao
K. Stefanaki
M Braoudaki
M Braoudaki
M Li
M Maschio
M Thom
M Wang
M. Braoudaki
N. Prodromou
P Zhou
R Kunder
S Lu
S Vella
S. A. Papadodima
SB Ng
TM Brinkman
X Zhang
Z Jamali
Publication date
30 January 2016
Publisher
'Springer Science and Business Media LLC'
Doi
Abstract
© Springer Science+Business Media New York 2015Among noncoding RNAs, microRNAs (miRNAs) have been most extensively studied, and their biology has repeatedly been proven critical for central nervous system pathological conditions. The diagnostic value of several miRNAs was appraised in pediatric dysembryoplastic neuroepithelial tumors (DNETs) using miRNA microarrays and receiving operating characteristic curves analyses. Overall, five pediatric DNETs were studied. As controls, 17 samples were used: the FirstChoice Human Brain Reference RNA and 16 samples from deceased children who underwent autopsy and were not present with any brain malignancy. The miRNA extraction was carried out using the mirVANA miRNA Isolation Kit, while the experimental approach included miRNA microarrays covering 1211 miRNAs. Quantitative real-time polymerase chain reaction was performed to validate the expression profiles of miR-1909* and miR-3138 in all samples initially screened with miRNA microarrays. Our findings indicated that miR-3138 might act as a tumor suppressor gene when down-regulated and miR-1909* as a putative oncogenic molecule when up-regulated in pediatric DNETs compared to the control cohort. Subsequently, both miRNA signatures might serve as putative diagnostic biomarkers for pediatric DNETs.Peer reviewedFinal Accepted Versio
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1007%2Fs12032-015-...
Last time updated on 11/11/2020
University of Hertfordshire Research Archive
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:uhra.herts.ac.uk:7504
Last time updated on 02/07/2025